bioAffinity
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations
Select Page
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 06, 2024 8:00am EST

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

Jan 30, 2024 8:00am EST

bioAffinity Technologies In The News

Jan 23, 2024 8:00am EST

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Jan 08, 2024 8:00am EST

bioAffinity Technologies In the News

Dec 05, 2023 8:00am EST

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

Nov 30, 2023 8:00am EST

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

Nov 28, 2023 8:00am EST

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

Nov 15, 2023 8:00am EST

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

Nov 14, 2023 4:01pm EST

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 06, 2023 8:00am EST

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …13
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed


Phone

(210) 698-5334



Email

info@bioaffinitytech.com



LinkedIn

…/bioaffinitytechnologies



Twitter

@bioAffinity

Subscribe for News from bioAffinity Technologies

Subscribe
Copyright © 2025 bioAffinity Technologies, Inc.